As of 2026-10-30, the Relative Valuation of Insmed Inc (INSM) is (114.29) USD. This relative valuation is based on P/E multiples. With the latest stock price at 111.59 USD, the upside of Insmed Inc based on Relative Valuation is -202.4%.
The range of the Relative Valuation is (113.88) - (113.80) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 28.2x - 30.8x | 29.5x |
| Forward P/E multiples | 25.7x - 28.2x | 27.1x |
| Fair Price | (113.88) - (113.80) | (114.29) |
| Upside | -202.1% - -202.0% | -202.4% |
| Date | P/E |
| 2026-10-29 | -27.63 |
| 2026-10-28 | -24.01 |
| 2026-10-27 | -23.51 |
| 2026-10-26 | -23.11 |
| 2026-10-23 | -23.13 |
| 2026-10-22 | -23.54 |
| 2026-10-21 | -23.29 |
| 2026-10-20 | -23.69 |
| 2026-10-19 | -23.60 |
| 2026-10-16 | -23.84 |
| 2026-10-15 | -24.57 |
| 2026-10-14 | -24.22 |
| 2026-10-13 | -23.97 |
| 2026-10-12 | -24.41 |
| 2026-10-09 | -24.91 |
| 2026-10-08 | -24.88 |
| 2026-10-07 | -25.19 |
| 2026-10-06 | -26.06 |
| 2026-10-05 | -25.71 |
| 2026-10-02 | -27.52 |
| 2026-10-01 | -26.89 |
| 2026-09-30 | -28.26 |
| 2026-09-29 | -28.63 |
| 2026-09-28 | -29.14 |
| 2026-09-25 | -29.18 |
| 2026-09-24 | -30.10 |
| 2026-09-23 | -29.30 |
| 2026-09-22 | -29.92 |
| 2026-09-21 | -29.96 |
| 2026-09-18 | -29.72 |
| 2026-09-17 | -30.70 |
| 2026-09-16 | -30.35 |
| 2026-09-15 | -29.70 |
| 2026-09-14 | -31.03 |
| 2026-09-11 | -32.05 |
| 2026-09-10 | -31.52 |
| 2026-09-09 | -31.89 |
| 2026-09-08 | -30.93 |
| 2026-09-04 | -31.27 |
| 2026-09-03 | -31.37 |
| 2026-09-02 | -31.36 |
| 2026-09-01 | -30.09 |
| 2026-08-31 | -30.17 |
| 2026-08-28 | -29.35 |
| 2026-08-27 | -30.06 |
| 2026-08-26 | -30.80 |
| 2026-08-25 | -30.68 |
| 2026-08-24 | -30.70 |
| 2026-08-21 | -31.14 |
| 2026-08-20 | -30.97 |